Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glioblastoma, Recurrent”

971 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 971 results

Testing effectiveness (Phase 2)Study completedNCT00050986
What this trial is testing

Phase I/II Evaluation of Temozolomide and ZARNESTRA (R115777) for Recurrent and Progressive Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
M.D. Anderson Cancer Center 55
Early research (Phase 1)Ended earlyNCT02168270
What this trial is testing

Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligodendrogliomaAnaplastic Oligoastrocytoma+2 more
University of Nebraska 4
Testing effectiveness (Phase 2)Study completedNCT00004937
What this trial is testing

Acridine Carboxamide in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC
Early research (Phase 1)Looking for participantsNCT06815029
What this trial is testing

Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma

Who this might be right for
Recurrent Astrocytoma, IDH-Mutant, Grade 3Recurrent Astrocytoma, IDH-Mutant, Grade 4Recurrent Glioblastoma
City of Hope Medical Center 27
Large-scale testing (Phase 3)Not Yet RecruitingNCT07349693
What this trial is testing

Comparison of Cerebraca Wafer Plus Temozolomide Versus Temozolomide Alone in Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma, IDH-Wildtype
Everfront Biotech Co., Ltd. 175
Early research (Phase 1)Not Yet RecruitingNCT07492316
What this trial is testing

RNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB)

Who this might be right for
Recurrent Medulloblastoma
University of Florida 24
Not applicableStudy completedNCT01009307
What this trial is testing

Study of Blood and Cheek Cell Samples From Patients With Glioma

Who this might be right for
Brain and Central Nervous System Tumors
University of California, San Francisco 1,709
Testing effectiveness (Phase 2)Study completedNCT00352521
What this trial is testing

Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) With Bevacizumab and Irinotecan for Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Duke University 20
Testing effectiveness (Phase 2)WithdrawnNCT06328036
What this trial is testing

Testing the Combination of Anti-cancer Drugs Tiragolumab and Atezolizumab to Improve Outcomes for Patients With Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma, IDH-Wildtype
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00075894
What this trial is testing

Alanosine in Treating Patients With Progressive or Recurrent Malignant Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI) 18
Not applicableStudy completedNCT00006342
What this trial is testing

Genetic Study in Patients Receiving Treatment for Hodgkin's Disease or Childhood Brain Tumor

Who this might be right for
Brain and Central Nervous System TumorsLymphoma
Duke University 19
Testing effectiveness (Phase 2)Ended earlyNCT01095094
What this trial is testing

Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma

Who this might be right for
Brain TumorAnaplastic AstrocytomaAnaplastic Ependymoma+6 more
Case Comprehensive Cancer Center 19
Early research (Phase 1)Ended earlyNCT01122888
What this trial is testing

Cilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma Multiforme

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+2 more
National Cancer Institute (NCI) 41
Very early researchLooking for participantsNCT05432518
What this trial is testing

Pilot Trial for Treatment of Recurrent Glioblastoma

Who this might be right for
GlioblastomaRecurrent DiseaseRecurrent Glioblastoma
AHS Cancer Control Alberta 10
Not applicableStudy completedNCT03626896
What this trial is testing

Safety of BBB Disruption Using NaviFUS System in Recurrent Glioblastoma Multiforme (GBM) Patients

Who this might be right for
Glioblastoma MultiformeBrain TumorGlioblastoma+3 more
NaviFUS Corporation 6
Testing effectiveness (Phase 2)WithdrawnNCT02754362
What this trial is testing

A Toll-like Receptor Agonist as an Adjuvant to Tumor Associated Antigens (TAA) Mixed With Montanide ISA-51 VG With Bevacizumab for Patients With Recurrent Glioblastoma

Who this might be right for
GlioblastomaGlioma
NYU Langone Health
Testing effectiveness (Phase 2)Study completedNCT01756352
What this trial is testing

FET-PET for Evaluation of Response of Recurrent GBM to Avastin

Who this might be right for
Glioblastoma MultiformeGBM
Marcelo F. Di Carli, MD, FACC 13
Testing effectiveness (Phase 2)Study completedNCT00629889
What this trial is testing

Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors

Who this might be right for
Brain and Central Nervous System TumorsSeizure
Dr Andrea Rossetti 52
Not applicableStudy completedNCT03997617
What this trial is testing

Personalized Functional Profiling in Metastatic Gastrointestinal Cancer or Recurrent Glioblastoma Patients in Luxembourg.

Who this might be right for
Oncology
Luxembourg Institute of Health 57
Testing effectiveness (Phase 2)Study completedNCT00362921
What this trial is testing

Gliadel Wafer and O6-Benzylguanine in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Recurrent Adult Brain Tumor
Duke University 52
Load More Results